Cardiotrophin 1

CTF1
Identifiers
AliasesCTF1, cardiotrophin 1, CT-1, CT1
External IDsOMIM: 600435; MGI: 105115; HomoloGene: 1016; GeneCards: CTF1; OMA:CTF1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

1489

13019

Ensembl

ENSG00000150281

ENSMUSG00000042340

UniProt

Q16619

Q60753

RefSeq (mRNA)

NM_001142544
NM_001330

NM_001301282
NM_001301283
NM_007795

RefSeq (protein)

NP_001136016
NP_001321

NP_001288211
NP_001288212
NP_031821

Location (UCSC)Chr 16: 30.9 – 30.9 MbChr 7: 127.31 – 127.32 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Cardiotrophin-1 (CT-1) is a protein encoded by the CTF1 gene in humans. It functions as a cytokine and acts as a 21.5 kDa cardiac hypertrophic factor. CT-1 belongs to the IL-6 cytokine family.

Tissue distribution

CT-1 is highly expressed in the heart, skeletal muscle, prostate and ovary and to lower levels in lung, kidney, pancreas, thymus, testis and small intestine. [5]

Mode of action

The protein exerts its cellular effects by interacting with the glycoprotein 130 (gp130)/leukemia inhibitory factor receptor beta (LIFR) heterodimer. In addition, CT-1 activates phosphatidylinositol 3-kinase (PI-3 kinase) in cardiac myocytes and enhances transcription factor NF-κB DNA -binding activities.

Clinical significance

CT-1 is associated with the pathophysiology of heart diseases, including hypertension, myocardial infarction, valvular heart disease, and congestive heart failure.

Exogenous administration of CT-1 in rodents has been found to mimic the beneficial effects of exercise on the heart in a rodent model of severe right-sided heart failure.[6][7][8][9][10]

CT-1 is under formal development for the treatment of reperfusion injury.[11] It is or was also under development for treatment of acute kidney injury, diabetes mellitus, ischemia, liver failure, and obesity, but no recent development for these indications has been reported.[11]

See also

References

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000150281Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000042340Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ "Recombinant human Cardiotrophin 1 protein (ab9838)". www.abcam.com. Retrieved 2017-08-09.
  6. ^ Zelt JG, Chaudhary KR, Cadete VJ, Mielniczuk LM, Stewart DJ (May 2019). "Medical Therapy for Heart Failure Associated With Pulmonary Hypertension". Circ Res. 124 (11): 1551–1567. doi:10.1161/CIRCRESAHA.118.313650. PMID 31120820.
  7. ^ Abdul-Ghani M, Suen C, Jiang B, Deng Y, Weldrick JJ, Putinski C, et al. (October 2017). "Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart". Cell Res. 27 (10): 1195–1215. doi:10.1038/cr.2017.87. PMC 5630684. PMID 28785017.
  8. ^ How to trick your heart into thinking you exercise, retrieved 15 March 2026
  9. ^ Watson SK (10 August 2017). "This protein makes your heart fit without actually exercising it". Popular Science. Retrieved 15 March 2026.
  10. ^ Buguliskis JS (8 August 2017). "Fooling the Heart to Be Healthier". GEN - Genetic Engineering and Biotechnology News. Retrieved 15 March 2026.
  11. ^ a b "Digna Biotech/Biotecnol". AdisInsight. 2 October 2021. Retrieved 15 March 2026.